Zimbabwe has rejected a substantial American healthcare agreement worth $367m (£272m) spanning five years over the United States' insistence on confidential information.
This move became public following a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".
A government spokesman later stated that the US was demanding access to genetic material for scientific study and commercial gain but refused to guarantee the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate task of scaling back our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has called for further dialogue to find a deal suitable to all parties so the country's vital HIV programme can proceed.
Broader Implications
Zimbabwe's decision comes after a similar situation in Kenya, where a high court halted a similar deal with the US following concerns were filed about the safety of Kenyans' health data.
Since resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered assistance for the American government, but Trump argued its expenditure was "inefficient" and his administration was seeking direct bilateral agreements to boost transparency and responsibility.
According to reports, 16 nations in Africa have so far agreed to these new health pacts, constituting over $18.3bn of fresh investment.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership would have delivered immense advantages for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy via US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana argued the proposed deal was "unfair".
"Zimbabwe was being asked to provide its biological resources and data indefinitely, without any equivalent assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that might be developed from that shared data," his statement read.
"Put simply, our country would supply the basic resources for medical research without any assurance that the final treatments would be accessible to our people should a new disease outbreak emerge."
National Interest and Global Health
He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were disrupting structures previously established via the global organization.
Mangwana cited its Pathogen Access and Benefit Sharing system created to manage potential global health emergencies.
"This mechanism is designed to ensure that when a country provides its data, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the resources to create them."
These objections regarding the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We are open to continued dialogue with our US partners on how future collaboration could be structured in a way that honours the independence and interests of each country."
Health Experts Response
A leading public health body stated it understood the official position, but recommended that negotiations need to persist given that much of the country's Aids initiatives depended on international support.
"Where specific concerns arise, such as those relating to information security or implementation frameworks, these can often be resolved via detailed discussion and negotiated safeguards," it said.
The halted deal underscores the complex tensions between receiving much-needed international aid and safeguarding national sovereignty in an increasingly interconnected world.